{"DataElement":{"publicId":"2517353","version":"1","preferredName":"Concomitant Anticoagulant Agent Administered Type","preferredDefinition":"the type of anticoagulant drug being administered that helps prevent blood clots from forming.","longName":"CONC_ANTICOAG_ADM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2517346","version":"1","preferredName":"Concomitant Anticoagulant Agent Administered","preferredDefinition":"information related to an anticoagulant, drug that helps prevent blood clots from forming, being administered at the same time as a treatment agent.","longName":"CONC_ANTICOAGAGT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2517324","version":"1","preferredName":"Concomitant Anticoagulant Agent","preferredDefinition":"Concomitant; following as a consequence.:Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.","longName":"C25730:C263","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant","conceptCode":"C25730","definition":"Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C574E36-0297-74FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C576BE8-F5DD-0486-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2517351","version":"1","preferredName":"Anticoagulant Agent Type","preferredDefinition":"the type of anticoagulant agent.","longName":"ANTICOAGAGT_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Aspirin 81mg","valueDescription":"Aspirin 81mg","ValueMeaning":{"publicId":"2580724","version":"1","preferredName":"Aspirin 81mg","longName":"2580724","preferredDefinition":"Aspirin 81mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0861-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56AD7B-0032-00C6-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Aspirin >81mg and <325mg","valueDescription":"Aspirin >81mg and <325mg","ValueMeaning":{"publicId":"2580723","version":"1","preferredName":"Aspirin >81mg and <325mg","longName":"2580723","preferredDefinition":"Aspirin >81mg and <325mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0860-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56AD7B-0044-00C6-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Aspirin > 325mg","valueDescription":"Aspirin > 325mg","ValueMeaning":{"publicId":"2580722","version":"1","preferredName":"Aspirin > 325mg","longName":"2580722","preferredDefinition":"Aspirin > 325mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-085F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56AD7B-0056-00C6-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Coumadin (prophylactic dose)","valueDescription":"Coumadin (prophylactic dose)","ValueMeaning":{"publicId":"2580721","version":"1","preferredName":"Coumadin (prophylactic dose)","longName":"2580721","preferredDefinition":"a prophylactic dose of the anticoagulant Coumadin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-085E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56AD7B-0068-00C6-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Coumadin (therapeutic dose)","valueDescription":"Coumadin (therapeutic dose)","ValueMeaning":{"publicId":"2580720","version":"1","preferredName":"Coumadin (therapeutic dose)","longName":"2580720","preferredDefinition":"a therapuetic dose of the anticoagulant Coumadin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-085D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56AD7B-007A-00C6-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Low Molecular Weight Heparin (prophylactic dose)","valueDescription":"Low Molecular Weight Heparin (prophylactic dose)","ValueMeaning":{"publicId":"2580726","version":"1","preferredName":"Low Molecular Weight Heparin (prophylactic dose)","longName":"2580726","preferredDefinition":"a prophylactic dose of the anticoagulant Low Molecular Weight Heparin.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0863-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56B70D-8FD4-00C4-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Low Molecular Weight Heparin (therapeutic dose)","valueDescription":"Low Molecular Weight Heparin (therapeutic dose)","ValueMeaning":{"publicId":"2580725","version":"1","preferredName":"Low Molecular Weight Heparin (therapeutic dose)","longName":"2580725","preferredDefinition":"a therapeutic dose of the anticoagulant Low Molecular Weight Heparin.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0862-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56B70D-8FE6-00C4-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C56B70D-8FF2-00C4-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"ONEDATA","dateModified":"2006-08-31","deletedIndicator":"No"},{"value":"Aspirin, other","valueDescription":"Aspirin, other","ValueMeaning":{"publicId":"2588585","version":"1","preferredName":"Aspirin, other","longName":"2588585","preferredDefinition":"Another dosage amount of acetylsalicylic acid.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2754A2CD-76C2-39D3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B87D7A-012D-18B8-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-06-12","modifiedBy":"ONEDATA","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"Aspirin 325mg","valueDescription":"Aspirin 325mg","ValueMeaning":{"publicId":"2588583","version":"1","preferredName":"Aspirin 325mg","longName":"2588583","preferredDefinition":"Aspirin 325mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2754903E-832C-3705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34979230-0331-2182-E044-0003BA3F9857","beginDate":"2007-07-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-06","modifiedBy":"ONEDATA","dateModified":"2007-07-06","deletedIndicator":"No"},{"value":"Coumadin","valueDescription":"Coumadin","ValueMeaning":{"publicId":"2663062","version":"1","preferredName":"Coumadin","longName":"2663062","preferredDefinition":"Coumadin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3497915B-FE39-2162-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34979230-0342-2182-E044-0003BA3F9857","beginDate":"2007-07-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-06","modifiedBy":"ONEDATA","dateModified":"2007-07-06","deletedIndicator":"No"},{"value":"Low Molecular Weight Heparin","valueDescription":"Low molecular weight heparin","ValueMeaning":{"publicId":"2573140","version":"1","preferredName":"Low molecular weight heparin","longName":"2573140","preferredDefinition":"Low molecular weight heparin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EAC1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"CAMPBELB","dateModified":"2005-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34979230-034E-2182-E044-0003BA3F9857","beginDate":"2007-07-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-06","modifiedBy":"ONEDATA","dateModified":"2007-07-06","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4063CA57-F7F8-4D30-E044-0003BA3F9857","beginDate":"2007-12-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-12-03","modifiedBy":"ONEDATA","dateModified":"2007-12-03","deletedIndicator":"No"},{"value":"Lovenox","valueDescription":"Lovenox","ValueMeaning":{"publicId":"3158276","version":"1","preferredName":"Lovenox","longName":"3158276","preferredDefinition":"Lovenox (enoxaparin) is used to prevent deep vein thrombosis (DVT), which which can lead to blood clots.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9490B1A2-4985-7D9D-E040-BB89AD433493","latestVersionIndicator":"Yes","beginDate":"2010-11-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9490B1A2-499E-7D9D-E040-BB89AD433493","beginDate":"2010-11-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-08","modifiedBy":"ONEDATA","dateModified":"2010-11-08","deletedIndicator":"No"},{"value":"Heparin","valueDescription":"Heparin","ValueMeaning":{"publicId":"3158277","version":"1","preferredName":"Heparin","longName":"3158277","preferredDefinition":"A glycosaminoglycan anticoagulant that binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heparin","conceptCode":"C539","definition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9490B1A2-49A8-7D9D-E040-BB89AD433493","latestVersionIndicator":"Yes","beginDate":"2010-11-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9490B1A2-49C0-7D9D-E040-BB89AD433493","beginDate":"2010-11-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-08","modifiedBy":"ONEDATA","dateModified":"2010-11-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C568B50-1A2D-07DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2015-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Anti-Coagulant Drugs","type":"Preferred Question Text","description":"Anti-Coagulant Drugs","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Perioperative DVT prophylaxis","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1C569A90-857D-0393-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"SHIDED","dateModified":"2010-11-08","changeDescription":"Lung Change Management 09/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}